Biora Therapeutics To Present On The BioJet Systemic Oral Delivery Platform At The Next Gen Peptide Formulation & Delivery Summit 2024
Portfolio Pulse from Benzinga Newsdesk
Biora Therapeutics, Inc. (NASDAQ:BIOR) will present preclinical data on its BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024 in Boston. The presentation will focus on needle-free smart capsules for peptide self-administration.
June 11, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biora Therapeutics will present preclinical data on its innovative BioJet™ Systemic Oral Delivery Platform at a major industry summit, potentially increasing investor interest and market visibility.
The presentation at a significant industry event could attract attention from investors and industry stakeholders, potentially leading to a positive short-term impact on BIOR's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100